A detailed history of Deutsche Bank Ag\ transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 42,531 shares of STRO stock, worth $80,808. This represents 0.0% of its overall portfolio holdings.

Number of Shares
42,531
Previous 28,177 50.94%
Holding current value
$80,808
Previous $82,000 79.27%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$2.88 - $5.01 $41,339 - $71,913
14,354 Added 50.94%
42,531 $147,000
Q2 2024

Aug 14, 2024

SELL
$2.92 - $5.33 $16,392 - $29,922
-5,614 Reduced 16.61%
28,177 $82,000
Q1 2024

May 15, 2024

BUY
$3.27 - $5.65 $3,999 - $6,909
1,223 Added 3.76%
33,791 $190,000
Q4 2023

Feb 14, 2024

SELL
$2.07 - $4.54 $2,512 - $5,511
-1,214 Reduced 3.59%
32,568 $139,000
Q3 2023

Nov 09, 2023

BUY
$3.29 - $4.9 $19,239 - $28,655
5,848 Added 20.94%
33,782 $117,000
Q2 2023

Aug 14, 2023

SELL
$4.25 - $5.88 $21,007 - $29,064
-4,943 Reduced 15.03%
27,934 $129,000
Q1 2023

May 15, 2023

BUY
$4.48 - $8.45 $44,808 - $84,516
10,002 Added 43.72%
32,877 $151,000
Q4 2022

Feb 13, 2023

BUY
$5.41 - $8.08 $27,937 - $41,725
5,164 Added 29.16%
22,875 $184,000
Q3 2022

Nov 14, 2022

SELL
$5.17 - $7.11 $15,215 - $20,924
-2,943 Reduced 14.25%
17,711 $98,000
Q2 2022

Aug 11, 2022

SELL
$3.41 - $8.95 $10,703 - $28,094
-3,139 Reduced 13.19%
20,654 $108,000
Q1 2022

May 13, 2022

SELL
$7.78 - $15.31 $259,517 - $510,695
-33,357 Reduced 58.37%
23,793 $195,000
Q4 2021

Feb 11, 2022

BUY
$14.25 - $23.53 $19,893 - $32,847
1,396 Added 2.5%
57,150 $850,000
Q3 2021

Nov 04, 2021

SELL
$16.88 - $22.38 $13,504 - $17,904
-800 Reduced 1.41%
55,754 $1.05 Million
Q2 2021

Aug 11, 2021

SELL
$18.03 - $23.82 $1.09 Million - $1.44 Million
-60,253 Reduced 51.58%
56,554 $1.05 Million
Q1 2021

May 13, 2021

SELL
$20.29 - $27.54 $1,765 - $2,395
-87 Reduced 0.07%
116,807 $2.66 Million
Q4 2020

Feb 16, 2021

BUY
$10.16 - $23.98 $1.04 Million - $2.46 Million
102,742 Added 725.99%
116,894 $2.54 Million
Q3 2020

Nov 12, 2020

BUY
$7.44 - $13.15 $44,111 - $77,966
5,929 Added 72.1%
14,152 $143,000
Q2 2020

Aug 13, 2020

BUY
$7.24 - $11.05 $35,070 - $53,526
4,844 Added 143.36%
8,223 $64,000
Q1 2020

May 14, 2020

SELL
$6.19 - $12.16 $25,874 - $50,828
-4,180 Reduced 55.3%
3,379 $34,000
Q4 2019

Feb 14, 2020

BUY
$8.15 - $11.39 $38,280 - $53,498
4,697 Added 164.12%
7,559 $82,000
Q3 2019

Nov 14, 2019

SELL
$7.91 - $11.76 $47,808 - $71,077
-6,044 Reduced 67.86%
2,862 $25,000
Q2 2019

Aug 14, 2019

SELL
$9.69 - $12.23 $4,292 - $5,417
-443 Reduced 4.74%
8,906 $100,000
Q1 2019

May 15, 2019

SELL
$8.8 - $11.87 $4,100 - $5,531
-466 Reduced 4.75%
9,349 $105,000
Q4 2018

Feb 14, 2019

BUY
$8.69 - $14.85 $85,292 - $145,752
9,815 New
9,815 $87,000

Others Institutions Holding STRO

About SUTRO BIOPHARMA, INC.


  • Ticker STRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,161,500
  • Market Cap $99.1M
  • Description
  • Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...
More about STRO
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.